News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Conference News TCT 2024 More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact Yael L. Maxwell October 28, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Daily News BP Reduction With Renal Denervation Still Evident a Decade On Michael O'Riordan January 31, 2023
News Daily News Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2 Yael L. Maxwell November 03, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Daily News Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults L.A. McKeown February 15, 2022
News Conference News ESC 2021 Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD Michael O'Riordan August 29, 2021
News Daily News Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk Todd Neale January 20, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020